Article: Targeted therapies promise new hope for brain cancer patients.

M2 PRESSWIRE-4 September 2007-DATAMONITOR: Targeted therapies promise new hope for brain cancer patients(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:05092007

London - Despite the many millions of dollars being invested into brain cancer research, primary brain cancer remains one of the most deadly diseases in the developed world. While primary brain tumors are relatively rare, the chances of survival for patients with the disease are very low, even with the best treatment options currently available. According to a new report* by Datamonitor, however, significant progress is being made with research into the disease and innovative new therapies may be able ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!